XM does not provide services to residents of the United States of America.

France's Atos cuts financial targets but says restructuring still on track



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 1-France's Atos cuts financial targets but says restructuring still on track</title></head><body>

Adds details and background from paragraph 3

By Tassilo Hummel

PARIS, Sept 2 (Reuters) -French IT firm Atos ATOS.PA on Monday said it would have less cash at hand over the next few years as sales are being dragged down by a weaker business environment, but added this would not impact the key terms of its financial restructuring plan.

Atos - once seen as one of Europe's champions in the software and technology sector - has been teetering on the brink of financial collapse in recent months, although it secured a crucialrestructuring deal with banks and bondholders in June.

Atos said it now forecasta full-year 2024 group revenue of 9.7 billion euros ($10.72 billion), down from 9.8 billion euros previously estimated. The company added it still saw positive, but somewhat lower, cash generation in 2026.

The group's operating margin will come in at 2.4% of revenue this year, down from 2.9% previously targeted.

The company's leverage ratio is also now expected to come below a multiple of 2.0 during 2027, later than a previous end-2026 deadline, and Atos also lowered its 2027 revenue and operating margin targets.

A court hearing for the approval of the accelerated safeguard plan will take place on October 15, Atos said.

Atos' restructuring plan, which is expected to result in massive dilution of existing shareholders, is set to be implemented following the court approval, with several capital increases and debt issuance planned from November 2024 until January 2025.

The company last month posted a wider first-half operating loss, citing impairment charges and lower sales in the Americas and a slowdown in public-sector orders in Europe.

($1 = 0.9048 euros)



Reporting by Tassilo Hummel;
Editing by Sudip Kar-Gupta

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.